TCL Archive In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI February 6, 1976
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
